User profiles for Claire Palles
Claire PallesUniversity of Birmingham Verified email at bham.ac.uk Cited by 9850 |
[HTML][HTML] COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
…, AFC Okines, AC Olsson-Brown, C Palles… - The Lancet, 2020 - thelancet.com
Background Individuals with cancer, particularly those who are receiving systemic anticancer
treatments, have been postulated to be at increased risk of mortality from COVID-19. This …
treatments, have been postulated to be at increased risk of mortality from COVID-19. This …
[HTML][HTML] COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
…, T Newsom-Davis, AC Olsson-Brown, C Palles… - The Lancet …, 2020 - thelancet.com
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
Many individuals with multiple or large colorectal adenomas or early-onset colorectal cancer
(CRC) have no detectable germline mutations in the known cancer predisposition genes. …
(CRC) have no detectable germline mutations in the known cancer predisposition genes. …
DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer
Accurate duplication of DNA prior to cell division is essential to suppress mutagenesis and
tumour development. The high fidelity of eukaryotic DNA replication is due to a combination …
tumour development. The high fidelity of eukaryotic DNA replication is due to a combination …
Clinical relevance of DPYD variants c. 1679T> G, c. 1236G> A/HapB3, and c. 1601G> A as predictors of severe fluoropyrimidine-associated toxicity: a systematic …
Background The best-known cause of intolerance to fluoropyrimidines is dihydropyrimidine
dehydrogenase (DPD) deficiency, which can result from deleterious polymorphisms in the …
dehydrogenase (DPD) deficiency, which can result from deleterious polymorphisms in the …
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries
Colorectal cancer (CRC) is a leading cause of mortality worldwide. We conducted a genome-wide
association study meta-analysis of 100,204 CRC cases and 154,587 controls of …
association study meta-analysis of 100,204 CRC cases and 154,587 controls of …
A panoply of errors: polymerase proofreading domain mutations in cancer
Although it has long been recognized that the exonucleolytic proofreading activity intrinsic
to the replicative DNA polymerases Pol δ and Pol ε is essential for faithful replication of DNA, …
to the replicative DNA polymerases Pol δ and Pol ε is essential for faithful replication of DNA, …
[HTML][HTML] Increased somatic mutation burdens in normal human cells due to defective DNA polymerases
Mutation accumulation in somatic cells contributes to cancer development and is proposed
as a cause of aging. DNA polymerases Pol ε and Pol δ replicate DNA during cell division. …
as a cause of aging. DNA polymerases Pol ε and Pol δ replicate DNA during cell division. …
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk
We performed a meta-analysis of five genome-wide association studies to identify common
variants influencing colorectal cancer (CRC) risk comprising 8,682 cases and 9,649 controls. …
variants influencing colorectal cancer (CRC) risk comprising 8,682 cases and 9,649 controls. …
POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
…, E Stelloo, E Marchi, M de Bruyn, C Palles… - Clinical Cancer …, 2015 - AACR
Purpose: Recent studies have shown that 7% to 12% of endometrial cancers are ultramutated
due to somatic mutation in the proofreading exonuclease domain of the DNA replicase …
due to somatic mutation in the proofreading exonuclease domain of the DNA replicase …